Literature DB >> 20409605

Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study.

Alessandro Cucchetti1, Fabio Piscaglia, Antonia D'Errico Grigioni, Matteo Ravaioli, Matteo Cescon, Matteo Zanello, Gian Luca Grazi, Rita Golfieri, Walter Franco Grigioni, Antonio Daniele Pinna.   

Abstract

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) prognosis strongly depends upon nuclear grade and the presence of microscopic vascular invasion (MVI). The aim of this study was to develop an artificial neural network (ANN) that is able to predict tumour grade and MVI on the basis of non-invasive variables.
METHODS: Clinical, radiological, and histological data from 250 cirrhotic patients resected (n=200) or transplanted (n=50) for HCC were analyzed. ANN and logistic regression models were built on a training group of 175 randomly chosen patients and tested on the remaining testing group of 75. Receiver operating characteristics curve (ROC) and k-statistics were used to analyze model accuracy in the prediction of the final histological assessment of tumour grade (G1-G2 vs. G3-G4) and MVI (absent vs. present).
RESULTS: Pathologic examination showed G3-G4 in 69.6% of cases and MVI in 74.4%. Preoperative serum alpha-fetoprotein (AFP), tumour number, size, and volume were related to tumour grade and MVI (p<0.05) and were used for ANN building, whereas, tumour number did not enter into the logistic models. In the training group, ANN area under ROC curves (AUC) for tumour grade and MVI prediction were 0.94 and 0.92, both higher (p<0.001) than those of logistic models (0.85 for both). In the testing group, ANN correctly identified 93.3% of tumour grades (k=0.81) and 91% of MVI (k=0.73). Logistic models correctly identified 81% of tumour grades (k=0.55) and 85% of MVI (k=0.57).
CONCLUSION: ANN identifies HCC tumour grades and MVI on the basis of preoperative variables more accurately than the conventional linear model and should be used for tailoring clinical management. Copyright 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20409605     DOI: 10.1016/j.jhep.2009.12.037

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  58 in total

1.  Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.

Authors:  Shi-Ting Feng; Yingmei Jia; Bing Liao; Bingsheng Huang; Qian Zhou; Xin Li; Kaikai Wei; Lili Chen; Bin Li; Wei Wang; Shuling Chen; Xiaofang He; Haibo Wang; Sui Peng; Ze-Bin Chen; Mimi Tang; Zhihang Chen; Yang Hou; Zhenwei Peng; Ming Kuang
Journal:  Eur Radiol       Date:  2019-01-28       Impact factor: 5.315

2.  Artificial neural network model for predicting 5-year mortality after surgery for hepatocellular carcinoma: a nationwide study.

Authors:  Hon-Yi Shi; King-Teh Lee; Jhi-Joung Wang; Ding-Ping Sun; Hao-Hsien Lee; Chong-Chi Chiu
Journal:  J Gastrointest Surg       Date:  2012-08-10       Impact factor: 3.452

3.  Safety and Efficacy of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma (3-5 cm): a Propensity Score Matching Cohort Study.

Authors:  Qing-Wang Ye; Shu-Jie Pang; Ning Yang; Hai-Bin Zhang; Yong Fu; Bin Lin; Guang-Shun Yang
Journal:  J Gastrointest Surg       Date:  2019-06-13       Impact factor: 3.452

4.  Delta-slope of alpha-fetoprotein improves the ability to select liver transplant patients with hepatocellular cancer.

Authors:  Quirino Lai; Milton Inostroza; Juan M Rico Juri; Pierre Goffette; Jan Lerut
Journal:  HPB (Oxford)       Date:  2015-09-16       Impact factor: 3.647

5.  Predictive models for patients with lung carcinomas to identify EGFR mutation status via an artificial neural network based on multiple clinical information.

Authors:  Xiaoyi Qin; Hailong Wang; Xiang Hu; Xiaolong Gu; Wei Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-05       Impact factor: 4.553

6.  The Predictors of Microscopic Vessel Invasion Differ Between Primary Hepatocellular Carcinoma and Hepatocellular Carcinoma with a Treatment History.

Authors:  Yukiyasu Okamura; Teiichi Sugiura; Takaaki Ito; Yusuke Yamamoto; Ryo Ashida; Takeshi Aramaki; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

7.  Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.

Authors:  Zheng Li; Zhengqing Lei; Yong Xia; Jun Li; Kui Wang; Han Zhang; Xuying Wan; Tian Yang; Weiping Zhou; Mengchao Wu; Timothy M Pawlik; Wan Yee Lau; Feng Shen
Journal:  JAMA Surg       Date:  2018-10-17       Impact factor: 14.766

8.  Contrast-enhanced ultrasonography parameters in neural network diagnosis of liver tumors.

Authors:  Costin Teodor Streba; Mihaela Ionescu; Dan Ionut Gheonea; Larisa Sandulescu; Tudorel Ciurea; Adrian Saftoiu; Cristin Constantin Vere; Ion Rogoveanu
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

9.  Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.

Authors:  Bin Jin; Zhiwei Gong; Nongguo Yang; Zhaoquan Huang; Sien Zeng; Hui Chen; Sanyuan Hu; Guangdong Pan
Journal:  Tumour Biol       Date:  2015-11-23

Review 10.  Prognostic factors for hepatocellular carcinoma recurrence.

Authors:  Antonio Colecchia; Ramona Schiumerini; Alessandro Cucchetti; Matteo Cescon; Martina Taddia; Giovanni Marasco; Davide Festi
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.